InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: epenephrine post# 43041

Saturday, 02/28/2015 1:41:59 PM

Saturday, February 28, 2015 1:41:59 PM

Post# of 424170
Thier argument is irrelevant, they admit that while they could grant exclusivity and have under similar circumstance they will not...8 generic filers want in and NCE delays this. They have no SPA rescinding answer...both are arbitrary and capricious and both directly harm Amarin and stakeholders...Tommorow I will scan and PDF you the 2014 Exclusivity Meeting ... It would be nice to get this new info to Committee hands before Hamburg comes to beg for money on Tuesday.

Any thoughts?

BB
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News